Cubist Systematic Strategies, LLC - RUBIUS THERAPEUTICS INC ownership

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 62 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of RUBIUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$8,000
-88.4%
18,270
-77.5%
0.00%
Q2 2022$69,000
-92.1%
81,055
-48.6%
0.00%
-100.0%
Q1 2022$869,000
+186.8%
157,786
+403.9%
0.01%
+133.3%
Q4 2021$303,000
+98.0%
31,315
+264.8%
0.00%
+50.0%
Q3 2021$153,000
-54.7%
8,585
-38.0%
0.00%
-50.0%
Q2 2021$338,000
+64.9%
13,842
+78.7%
0.00%
+33.3%
Q1 2021$205,000
+21.3%
7,748
-56.4%
0.00%0.0%
Q4 2019$169,000
+56.5%
17,789
+29.3%
0.00%
+50.0%
Q3 2019$108,00013,7580.00%
Other shareholders
RUBIUS THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 38,506,526$6,546,1090.21%
HARBOURVEST PARTNERS LLC 986,878$172,7040.06%
Artal Group S.A. 2,042,666$3570.02%
Virtu Financial LLC 68,825$120.00%
ACADIAN ASSET MANAGEMENT LLC 1,277,196$2220.00%
STATE OF MICHIGAN RETIREMENT SYSTEM 640,000$110,1440.00%
Baillie Gifford 4,869,126$837,9770.00%
Citadel Advisors 600$1030.00%
Tower Research Capital LLC (TRC) 25$00.00%
JPMORGAN CHASE & CO 2,196$00.00%
View complete list of RUBIUS THERAPEUTICS INC shareholders